SARS-CoV-2/COVID-19 Prevalence Study

CompletedOBSERVATIONAL
Enrollment

26,741

Participants

Timeline

Start Date

February 4, 2021

Primary Completion Date

August 12, 2021

Study Completion Date

August 12, 2021

Conditions
COVID-19
Trial Locations (15)

10027

Harlem Prevention, New York

10032

Physicians & Surgeons CRS, New York

10451

Bronx Prevention Center, New York

15260

University of Pittsburgh, Pittsburgh

19104

Penn Prevention CRS, Philadelphia

21218

John's Hopkins CRS, Baltimore

30308

The Ponce de Leon Center CRS, Atlanta

33136

U of Miami, IDRU at Jackson Memorial Hospital CRS, Miami

45229

Cincinnati CRS, Cincinnati

60612

UIC Project Wish CRS, Chicago

70118

New Orleans Adolescent Trials Unit CRS, New Orleans

77030

Baylor College of Medicine, Houston

80045

Children's Hospital Colorado CRS, Aurora

07103

New Jersey Medical School CRS, Newark

Unknown

St. Louis University VTEU-CAIMED-PHSU, Ponce

All Listed Sponsors
lead

COVID-19 Prevention Network

NETWORK

NCT04658121 - SARS-CoV-2/COVID-19 Prevalence Study | Biotech Hunter | Biotech Hunter